Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AbnobaViscum in Malignant Pleural Effusion
NCT02191540Phase 3Completed
- Sponsor
- ABNOBA GmbH
- Start
- Jan 2011
- Primary completion
- Jan 2013
- Modality
- PE (Plant Extract)
- Countries
- 1
01
Overview
A Phase 3 trial of abnobaVISCUM Fraxini in malignant pleural effusion (MPE), sponsored by ABNOBA GmbH. Started Jan 2011; status: completed.
02
Drugs
abnobaVISCUM Fraxini
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on NCT02191540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02191540.